4.4 Article

Implementation of a Molecular Tumor Registry to Support the Adoption of Precision Oncology Within an Academic Medical Center: The Duke University Experience

Related references

Note: Only part of the references are listed.
Article Oncology

Results and Clinical Utilization of Foundation Medicine Molecular Tumor Profiling in Uterine and Ovarian Cancers

Catherine H. Watson et al.

Summary: A retrospective study was conducted to evaluate the actionability and clinical utilization of molecular tumor profiling in uterine and ovarian cancers using Foundation Medicine testing. Majority of tests were ordered after recurrence diagnosis, with 32% showing no actionable molecular alterations. Only 7% had alterations directing to FDA-approved therapy, and treatment was initiated in 15% of patients with actionable findings.

TARGETED ONCOLOGY (2021)

Review Pathology

Enabling Precision Oncology Through Precision Diagnostics

Noah A. Brown et al.

ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 15, 2020 (2020)

Article Medicine, General & Internal

Implementation and use of whole exome sequencing for metastatic solid cancer

Manon Reda et al.

EBIOMEDICINE (2020)

Article Medicine, General & Internal

Olaparib for Metastatic Castration-Resistant Prostate Cancer

J. de Bono et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

Capmatinib in MET Exon 14-Mutated or MET-Amplified Non-Small-Cell Lung Cancer

Juergen Wolf et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer

Fabrice Andre et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Medicine, General & Internal

Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer

Talia Golan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Medicine, General & Internal

Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma

Y. Loriot et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Oncology

Clinical utility of FoundationOne tissue molecular profiling in men with metastatic prostate cancer

Jason Zhu et al.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2019)

Article Medicine, General & Internal

Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer

S. Kopetz et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Review Oncology

Management of toxicity to isoform α-specific PI3K inhibitors

S. E. Nunnery et al.

ANNALS OF ONCOLOGY (2019)

Article Medicine, General & Internal

Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children

A. Drilon et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Oncology

NCCN Oncology Research Program's Investigator Steering Committee and NCCN Best Practices Committee Molecular Profiling Surveys

Razelle Kurzrock et al.

Journal of the National Comprehensive Cancer Network (2017)

Article Oncology

On the Road to Precision Cancer Medicine: Analysis of Genomic Biomarker Actionability in 439 Patients

Maria Schwaederle et al.

MOLECULAR CANCER THERAPEUTICS (2015)

Article Oncology

Physicians' Attitudes About Multiplex Tumor Genomic Testing

Stacy W. Gray et al.

JOURNAL OF CLINICAL ONCOLOGY (2014)

Article Biotechnology & Applied Microbiology

Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing

Garrett M. Frampton et al.

NATURE BIOTECHNOLOGY (2013)

Article Computer Science, Interdisciplinary Applications

Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support

Paul A. Harris et al.

JOURNAL OF BIOMEDICAL INFORMATICS (2009)